We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPECW
12401
DELISTED
Spectaire Holdings, Inc. Warrant
SPECW
$15K ﹤0.01%
154,448
-3,270
-2% -$468
AVGR
12402
DELISTED
Avinger, Inc. Common Stock
AVGR
$15K ﹤0.01%
+705
New +$23.4K
GMVD
12403
DELISTED
G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
$15K ﹤0.01%
723
-711
-50% -$22.4K
OTMO
12404
CALL
DELISTED
Otonomo Technologies Ltd. Ordinary shares
OTMO
$15K ﹤0.01%
913
-600
-40% -$12.8K
DOMA
12405
PUT
DELISTED
Doma Holdings, Inc.
DOMA
$15K ﹤0.01%
584
-2,312
-80% -$98.2K
AGTC
12406
CALL
DELISTED
Applied Genetic Technologies Corporation
AGTC
$15K ﹤0.01%
18,900
+5,900
+45% +$5.26K
MKD
12407
DELISTED
Molecular Data Inc. American Depositary Shares
MKD
$15K ﹤0.01%
27,603
+19,889
+258% +$28.7K
APRE icon
12408
Aprea Therapeutics
APRE
$8.42M
$14K ﹤0.01%
944
-2,910
-76% -$67.1K
DPRO
12409
PUT
Draganfly
DPRO
$182M
$14K ﹤0.01%
616
-1,400
-69% -$43.5K
GALT icon
12410
PUT
Galectin Therapeutics
GALT
$347M
$14K ﹤0.01%
+10,700
New +$15.4K
IGC icon
12411
PUT
IGC Pharma
IGC
$31.1M
$14K ﹤0.01%
27,200
-8,000
-23% -$5.05K
CD
12412
Chaince Digital Holdings
CD
$436M
$14K ﹤0.01%
21,316
+2,370
+13% +$3.89K
MITQ icon
12413
Moving iMage Technologies
MITQ
$5.47M
$14K ﹤0.01%
+10,526
New +$12.4K
VERO
12414
DELISTED
Venus Concept
VERO
$14K ﹤0.01%
+191
New +$26.9K
KRNLW
12415
DELISTED
Kernel Group Holdings, Inc. Warrants
KRNLW
$14K ﹤0.01%
129,387
+1,473
+1% +$243
RAAS
12416
CALL
DELISTED
Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares)
RAAS
$14K ﹤0.01%
4,300
+900
+26% +$2.9K
ASAP
12417
PUT
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$14K ﹤0.01%
4,675
-60
-1% -$265
ADVM
12418
PUT
DELISTED
Adverum Biotechnologies
ADVM
$13K ﹤0.01%
1,110
-6,290
-85% -$65.9K
BLRX
12419
CALL
BioLineRX
BLRX
$12M
$13K ﹤0.01%
258
-17
-6% -$945
CALC icon
12420
PUT
CalciMedica
CALC
$20.8M
$13K ﹤0.01%
850
-86
-9% -$1.17K
CATX icon
12421
Perspective Therapeutics
CATX
$365M
$13K ﹤0.01%
4,102
-8,592
-68% -$26.2K
CRIS icon
12422
PUT
Curis
CRIS
$3.76M
$13K ﹤0.01%
32
-11
-26% -$4.59K
ORIO
12423
Orion Digital Corp
ORIO
$20.1M
$13K ﹤0.01%
+5,180
New +$24.6K
PTPI
12424
PUT
DELISTED
Petros Pharmaceuticals
PTPI
$13K ﹤0.01%
63
-164
-72% -$41.1K
UNCY icon
12425
Unicycive Therapeutics
UNCY
$153M
$13K ﹤0.01%
1,521
-2,199
-59% -$21K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.